期刊文献+

胰腺癌中雌激素受体α与β的表达 被引量:3

Expression of estrogen receptor α,β protein and mRNA in pancreatic cancer
下载PDF
导出
摘要 目的 :检测胰腺癌中雌激素受体α、β(ERα、ERβ)蛋白和mRNA的表达。 方法 :采用免疫组化和RT PCR检测 5 0例胰腺癌和 2 0例乳腺癌患者ERα、ERβ蛋白的表达以及ERα、ERβmRNA的表达情况。 结果 :胰腺癌ERα蛋白的阳性率为 32 % ,ERβ蛋白的阳性率为 38%。胰腺癌ERαmRNA表达水平低于ER(- )的乳腺癌 ,胰腺癌ERβmRNA的表达水平明显高于ER(+)和ER(- )的乳腺癌。胰腺癌ERαmRNA/ERβmRNA的比值明显低于ER(+)和ER(- )的乳腺癌。结论 :ERβ在胰腺癌的发生。 Objective:To detect the expression of estrogen receptor α,β protein and mRNA in pancreatic cancer.Methods:The expression of estrogen receptor α,β protein and mRNA in 50 cases of pancreatic cancer and 20 case of mammary cancer was studied using the method of immunohistochemistry and RT PCR,respectively.Results:The positive ratio of ERα,ERβ protein was 32% and 38%,respectively;the mRNA level of ERα in pancreatic cancer was lower than that in ER(-) mammary cancer,on the other hand,the expression level of ERβ mRNA in pancreatic cancer was higher than that in mammary cancer no matter it's ER(+) or ER(-);the ratio of ERα mRNA/ERβ mRNA in pancreatic cancer was lower than that in mammary cancer.Conclusion:ERβ may play an important role in pancreatic cancer.
出处 《肝胆胰外科杂志》 CAS 2004年第2期100-102,共3页 Journal of Hepatopancreatobiliary Surgery
关键词 胰腺肿瘤 受体 雌激素Α受体 雌激素β pancreatic neoplasms ERα ERβ
  • 相关文献

参考文献9

  • 1李胜,李占元,石学涛,仲伟霞,衣龙海.胰腺癌组织中雌激素受体表达及临床应用其拮抗剂三苯氧胺的疗效观察[J].中华普通外科杂志,2002,17(10):626-626. 被引量:3
  • 2Mc Clendon JE,Appleby D,Claudon DB,et al. Colonic neoplasms:ti ssue estrogen receptor and carcinoembryonic antigen[J]. Arch Surg,1977,112(3) :240-2 41.
  • 3Krust A,Green S,Argos P,et al. The chicken oestrogen receptor s equence:h omology with v-erbA and the human oestrogen and glucocorticoid receptors[J]. EMBO J,1986,5(5):891-897.
  • 4Katzenellenbogen BS. Estrogen receptors: bioactivities and intera ctions with cell signaling pathways[J]. Biol Reprod,1996,54(2):287-293.
  • 5Leygue E,Dotzlaw H,Watson PH,et al. Expression of estrogen rece ptor beta1,beta2,and beta5 messenger RNAs in human breast tissue[J]. Cancer Res,1999,59(6):1175-1179.
  • 6Delaunay F,Pettersson K,Tujague M,et al. Functional differences between th e amino-terminal domains of estrogen receptors alpha and beta[J]. Mol Pharmac ol,2000,58(3):584-590.
  • 7Hall JM,McDonnell DP. The estrogen receptor beta-isoform(ERbeta) of the hu man estrogen receptor modulates ERalpha transcriptional activity and is a key re gulator of the cellular response to estrogens and antiestrogens[J]. Endocrinol ogy,1999,140(12):5566-5578.
  • 8Gustafsson JA. Estrogen receptor beta in the breast:role in estr ogen responsiveness and development of breast cancer[J]. J Steroid Biochem Mol Biol ,2000,74(5):245-248.
  • 9Cullen R,MaGuire T,Diggin P,et al. Detection of estrogen receptor-beta mRNA in breast cancer using RT-PCR[J]. Int J Biol Markers,2000 ,15(1):114-115.

二级参考文献1

共引文献2

同被引文献45

  • 1李胜,赵希义,王春英,仲伟霞,衣龙海.胰腺癌中ERα变异体的表达[J].胰腺病学,2004,4(3):159-162. 被引量:1
  • 2Somigliana E, Vigano P, Tirellia S, et al. Use of the concomitant serum dosage of CA125, CA19 -9 and interleukin -6 to detect the presence of endometriosis results from a series of reproductive age women undergoing laparoscopic surgery for benign gynaecological conditions [ J ]. Human Reproduction. 2004. 19(8) :1871 - 1876.
  • 3Oya Uygur-Bayramicli,Resat Dabak,Ekrem Orbay,Can Dolapclo■lu,Mehmet Sargin,Gamze Kilico■lu,Yüksel Güleryüzlü,Alpaslan Mayada■li.Type 2 diabetes mellitus and CA 19-9 levels[J].World Journal of Gastroenterology,2007,13(40):5357-5359. 被引量:64
  • 4Shibata K, Iwaki K,Kai S,et al. Increased levels of bothcarbohydrate antigen 19-9 and duke pancreatic monoclonalantigen type 2 reflect postoperative prognosis in patients withpancreatic carcinoma[J]. Pancreas, 2009,38(3):619-624.
  • 5Goonetilleke K S, Siriwardena A K. Systematic review ofcarbohydrate antigen(CA 19-9)as a biochemical marker inthe diagnosis of pancreatic cance[J]. Eur J Surg Oncol,2007,33(3):266-270.
  • 6Murray M D, Burton F R, Di Bisceglie A M. Markedlyelevated serum CA 19-9 levels in association with a benignbiliary stricture due to primary sclerosing cholangitis[J]. J ClinGastroenterol, 2007 ,41(4): 115-117.
  • 7Gul K, Nas S,Ozdemir D, et al. CA 19-9 level in patientswith type 2 diabetes mellitus and its relation to the metaboliccontrol and microvascular complications[J]. Am J Med Sci,2011,341(l):28-32.
  • 8Somigliana E, Vigano P, Tirellia S. Use of the concomitantserum dosage of CA125 , CA19-9 and interleukin-6 to detectthe presence of endometriosis results from a series ofreproductive age women undergoing laparoscopic surgery forbenign gynaecological conditions[J]. Hum Reprod, 2004,19(8):1871-1876.
  • 9Siegel R,Naishadham D,Jemal A. Cancer statistics,2013 [ J]. CA Cancer J Clin,2013,63 ( 1 ) : 11 - 30.
  • 10Simard EP, Ward EM, Siegel R, et al. Cancers with increasing inci- dence trends in the United States: 1999 through 2008 [ J]. CA Cancer J Clin,2012,188(4) :1120 - 1123.

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部